The usage of over-the-counter products by private insured patients in Germany - a claims data analysis with focus on complementary medicine.
Katja GoetzMatthias KalderUte-Susann AlbertChristian O JackePublished in: BMC health services research (2020)
The analysis of OTC drugs is feasible when the main and the peripheral assortment is available and enable to integrate about 18% of all OTCs, which are neglected by the common ATC-based approach. The presented extended approach may help to identify potential users of OTCs or people in need of OTC use. In case of the highly disputed homeopathy and anthroposophy products, more research among interactions with prescriptions drugs (Rx), nutrition's and other potentially harmful exposures is recommended.